United Therapeutics (UTHR) Misses Q4 EPS by $2.05, Misses on Revenue
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $517.06 +1.69%
Financial Fact:
Total revenues: 408.2M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Total revenues: 408.2M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q4 EPS of $2.67, $2.05 worse than the analyst estimate of $4.72. Revenue for the quarter came in at $491.5 million versus the consensus estimate of $519.21 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Prenetics Global (PRE) Tops Q2 EPS by 18c
- Eltek Ltd (ELTK) Reports Q2 EPS of $0.41
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
